Stryker cuts 2026 outlook after Q3 miss, shares tumble

Stryker reported third‑quarter 2026 adjusted earnings of $3.52 per diluted share and revenue of $6.5 billion, both below analyst expectations. The company lowered its full‑year organic net‑sales growth forecast to 6.5%‑7% and adjusted EPS guidance to $14.80‑$14.90, down from $14.95‑$15.10. CEO Kevin Lobo announced he will step down at year‑end, naming COO Spencer Stiles as his successor.

The guidance cut reduces the earnings outlook for the year, which may pressure the stock and affect investors’ valuation models (the company disclosed the new EPS range in its earnings release). The CEO transition adds uncertainty about execution of the upcoming product launches and strategic investments.

  • 1Adjusted earnings per diluted share for Q3 2026 were $3.52.
  • 2Q3 2026 revenue was $6.5 billion.
  • 3Organic sales grew 7.7% year‑over‑year in Q3.
  • 4Full‑year 2026 organic net‑sales growth guidance was revised to 6.5%‑7%.
  • 5Full‑year 2026 adjusted EPS guidance was revised to $14.80‑$14.90.
  • 6CEO Kevin Lobo will step down at year‑end, with COO Spencer Stiles slated to succeed him.

Sources